{"id":"NCT02554383","sponsor":"Nader Shaikh","briefTitle":"Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?","officialTitle":"Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2022-03-31","completion":"2023-03-09","firstPosted":"2015-09-18","resultsPosted":"2023-06-08","lastUpdate":"2023-06-29"},"enrollment":515,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sinusitis","Respiratory Tract Infections"],"interventions":[{"type":"DRUG","name":"Amoxicillin-clavulanate","otherNames":["Augmentin-Extra strength"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Treatment A","type":"ACTIVE_COMPARATOR"},{"label":"Treatment B","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this trial is to determine whether certain subgroups of children with acute sinusitis exist in whom antibiotic therapy can be appropriately withheld.","primaryOutcome":{"measure":"The Mean Pediatric Rhinosinusitis Symptom Scale (PRSS) Score Over the First 10 Days of Follow-up According to the Presence of Pathogens in the Nasopharynx at Enrollment","timeFrame":"Days 2 to 11","effectByArm":[{"arm":"Amoxicillin-clavulanate","deltaMin":17.3,"sd":7.8},{"arm":"Placebo","deltaMin":18.6,"sd":7.6}],"pValues":[{"comp":"OG000 vs OG001","p":"0.02"},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":11},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["37490085"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":254},"commonTop":["Diarrhea"]}}